Scientific Name: Retatrutide
Manufacturer: Zhengzhou Pharmaceutical (ZPHC)
Form: 5 vials × 12 mg (total 60 mg)
Category: Metabolic/weight‑management research compound
Mechanism: Retatrutide is a dual incretin agonist (GLP‑1 and GIP) that supports rapid weight‑loss, appetite regulation, and glycaemic balance.
⚗️ Storage & Handling
-
Refrigerate at 35–40 °F (2–4 °C)
-
Stable for 30 days at 25 °C (room temperature) for travel
-
Keep solution clear and particle‑free; discard if cloudy or discolored
-
For research use only — not approved for human consumption outside supervised protocols
Parameter Standard Range Notes Total content 60 mg 5 vials × 12 mg Administration Subcutaneous injection Abdomen, thigh, or upper arm Cycle length 12–24 weeks Depends on study design Research focus Appetite control, weight‑loss, glycaemic balance Dual incretin agonist Timing fasted (morning)
